Evidence map›Paper›PMID 39073787›Full record

ArticleFuture microbiology2024

Diagnosis and treatment of a patient with pulmonary infection caused by

Yifang Jiang, Ruixin Tian, Chi Zhang, Lujie Zhang, Xiaoman Cui, Ping Wang

Abstract readCase Reports
In one paragraph

Article in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. A case report ofFrontiers in medicine · 2026
    Article
  3. Diagnosis and treatment of a patient with mediastinal infection caused byFrontiers in cellular and infection microbiology · 2026
    Article
  4. Cavitary nodule caused byFrontiers in medicine · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yifang JiangDepartment of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
Ruixin TianDepartment of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
Chi ZhangDepartment of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
Lujie ZhangDepartment of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
Xiaoman CuiDepartment of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
Ping WangDepartment of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.ORCID 0009-0003-6236-8476

Funding

Hebei Provincial Department of Science and Technology of the key research and development program projects 22377715DHebei Provincial Health Commission of the Hebei medical application technology tracking project plan GZ2023038
6 · The paper itself

Abstract

Emergomycosis is a dimorphic fungal disease that is typically disseminated and fatal among immunocompromised individuals. In the case report, we presented a patient with intermittent fever, night sweats, coughing and phlegm. Chest computed tomography revealed multiple soft-tissue nodules in both lungs. Routine pathological and microbiological tests did not confirm the diagnosis. Therefore, we conducted pathogen detection using metagenomic next-generation sequencing in bronchoalveolar lavage fluid and identified the pulmonary infection caused by

Indexed as

Antifungal AgentsBronchoalveolar Lavage FluidLung Diseases, FungalHigh-Throughput Nucleotide SequencingHumansImmunocompromised HostLungMetagenomicsTomography, X-Ray ComputedAntifungal AgentsEmergomyces orientalisemergomycosisfungal therapymetagenomic next-generation sequencingpulmonary infection

Identifiers

PMID39073787
PMCPMC11633394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.